Medi Assist Healthcare Services Ltd
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]
- Market Cap ₹ 3,004 Cr.
- Current Price ₹ 403
- High / Low ₹ 594 / 385
- Stock P/E 48.7
- Book Value ₹ 77.8
- Dividend Yield 0.00 %
- ROCE 18.7 %
- ROE 17.4 %
- Face Value ₹ 5.00
Pros
Cons
- Promoter holding is low: 4.62%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance Insurance Distributors
Part of BSE Allcap BSE Financial Services
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 277 | 319 | 323 | 394 | 505 | 635 | 723 | 852 | |
| 194 | 237 | 247 | 302 | 385 | 501 | 569 | 685 | |
| Operating Profit | 82 | 82 | 76 | 92 | 120 | 133 | 154 | 167 |
| OPM % | 30% | 26% | 23% | 23% | 24% | 21% | 21% | 20% |
| -14 | 7 | 11 | 21 | 12 | -5 | 24 | 11 | |
| Interest | 4 | 4 | 6 | 3 | 3 | 3 | 10 | 25 |
| Depreciation | 23 | 27 | 32 | 28 | 27 | 43 | 56 | 70 |
| Profit before tax | 41 | 59 | 49 | 81 | 102 | 82 | 112 | 82 |
| Tax % | 37% | 41% | 47% | 21% | 28% | 16% | 18% | |
| 26 | 35 | 26 | 64 | 74 | 69 | 92 | 56 | |
| EPS in Rs | 7,254.85 | 9,576.18 | 7,064.52 | 9.33 | 10.76 | 9.53 | 12.89 | 7.92 |
| Dividend Payout % | 0% | 0% | 0% | 20% | 18% | 26% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 22% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 12% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 17% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 0.04 | 0.04 | 34 | 34 | 35 | 35 | 35 |
| Reserves | 218 | 212 | 290 | 303 | 342 | 437 | 506 | 544 |
| 98 | 115 | 35 | 27 | 31 | 26 | 204 | 305 | |
| 202 | 231 | 220 | 238 | 295 | 344 | 412 | 536 | |
| Total Liabilities | 518 | 558 | 545 | 602 | 702 | 842 | 1,158 | 1,420 |
| 142 | 138 | 119 | 99 | 171 | 246 | 306 | 679 | |
| CWIP | 3 | 1 | 1 | 6 | 0 | 3 | 4 | 0 |
| Investments | 88 | 72 | 111 | 201 | 44 | 77 | 274 | 91 |
| 285 | 347 | 315 | 296 | 487 | 516 | 574 | 650 | |
| Total Assets | 518 | 558 | 545 | 602 | 702 | 842 | 1,158 | 1,420 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 35 | 19 | 139 | 64 | 81 | 66 | 138 | |
| -21 | -22 | -61 | -83 | -10 | -55 | -218 | |
| -10 | -12 | -10 | -30 | -32 | -15 | 112 | |
| Net Cash Flow | 4 | -15 | 69 | -49 | 39 | -3 | 32 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 119 | 78 | 137 | 110 | 92 | 103 | 112 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 119 | 78 | 137 | 110 | 92 | 103 | 112 |
| Working Capital Days | -80 | -103 | -73 | -59 | -66 | -43 | -105 |
| ROCE % | 20% | 19% | 23% | 26% | 23% | 19% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 2d
-
Intimation On Submission Of Application To Stock Exchanges For Reclassification Of Certain Promoters From 'Promoter And Promoter Group' Category To 'Public' Category
11 Feb - Filed Feb 10, 2026 application to BSE/NSE to reclassify six promoters to public; all hold NIL shares.
-
Announcement under Regulation 30 (LODR)-Credit Rating
10 Feb - Care Ratings reaffirmed MAITPA: ₹152cr LT CARE AA-; ₹94cr LT/ST CARE AA-/CARE A1+; term loan withdrawn.
-
Announcement under Regulation 30 (LODR)-Credit Rating
10 Feb - Care Ratings reaffirmed MAHS ratings: ₹10.25Cr CARE AA-; ₹5.75Cr CARE AA-/A1+; Stable outlook (Feb 9, 2026).
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
9 Feb - Audio recording of Medi Assist's earnings call for Q3 and 9M FY26 (ended Dec 31, 2025) published. Checklist: - Identify announcement type and key content …
Annual reports
Concalls
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Sep 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
Business Profile[1] Company provides third-party administration (TPA) services to insurance companies through its wholly-owned Subsidiaries, Medi Assist TPA, Medvantage TPA, and Raksha TPA. A third-party administrator is an organization that processes health insurance claims for insurance companies and provides services such as policy administration, customer service, and network management, among others.